We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

134 hedge funds and large institutions have $238M invested in Viking Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

476% more call options, than puts

Call options by funds: $8.98M | Put options by funds: $1.56M

5% more capital invested

Capital invested by funds: $227M → $238M (+$11M)

0.19% less ownership

Funds ownership: 48.49% → 48.3% (-0.19%)

3% less funds holding

Funds holding: 138 → 134 (-4)

15% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 47

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
134
Holders Change
-4
Holders Change %
-2.9%
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
40
Reduced
47
Closed
12
Calls
$8.98M
Puts
$1.56M
Net Calls
+$7.42M
Net Calls Change
+$1.98M

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$5.13M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.66M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$1.99M
4
UBS Group
UBS Group
Switzerland
+$635K
5
First Trust Advisors
First Trust Advisors
Illinois
+$611K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$5.83M
2
Citigroup
Citigroup
New York
-$1.21M
3
Morgan Stanley
Morgan Stanley
New York
-$1.18M
4
Goldman Sachs
Goldman Sachs
New York
-$935K
5
ACM
ACT Capital Management
Pennsylvania
-$770K
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
101
Zurich Cantonal Bank
Switzerland
$51K – – –
AIP
102
Ameritas Investment Partners
Nebraska
$35K – – –
IA
103
IFP Advisors
Florida
$32K +$185 +30 +1%
US Bancorp
104
US Bancorp
Minnesota
$29K -$1.8K -291 -6%
Canada Life
105
Canada Life
Manitoba, Canada
$24K – – –
Rockefeller Capital Management
106
Rockefeller Capital Management
New York
$20K +$3.09K +500 +18%
DFCM
107
Dark Forest Capital Management
Puerto Rico
$17K +$12.9K +2,081 +317%
PGAM
108
Princeton Global Asset Management
New Jersey
$16K – – –
FPS
109
Fieldpoint Private Securities
Connecticut
$15K – – –
PNC Financial Services Group
110
PNC Financial Services Group
Pennsylvania
$13K – – –
APA
111
American Portfolios Advisors
New York
$12.6K – – –
MIFH
112
Migdal Insurance & Financial Holdings
Israel
$12K +$11.9K +1,924 New
PA
113
Parallel Advisors
California
$10K – – –
SWA
114
SOA Wealth Advisors
New York
$10K – – –
KTC
115
Kistler-Tiffany Companies
Pennsylvania
$9K – – –
First Manhattan
116
First Manhattan
New York
$6K – – –
FHA
117
First Horizon Advisors
Tennessee
$4K – – –
LC
118
Lindbrook Capital
California
$4K – – –
MA
119
Montag & Associates
Georgia
$4K – – –
CFD
120
Creative Financial Designs
Indiana
$3K – – –
HI
121
Harbour Investments
Wisconsin
$3K +$25 +4 +0.8%
PWM
122
Prentice Wealth Management
New York
$2K -$927 -150 -33%
GWM
123
Geneos Wealth Management
Colorado
$2K – – –
SSB
124
Sandy Spring Bank
Maryland
$2K – – –
TWA
125
TCI Wealth Advisors
Arizona
$2K – – –
2 3 4
5
6

VKTX Hedge Fund Activity: Q3 2021 in Review

134 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2021, worth a combined $238M — up 4.9% from $227M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of VKTX and 9 opened new positions — a net loss of 3 holders — while 47 trimmed existing stakes and 40 added.

The largest buyer was Nuveen, adding an estimated $5.13M. The largest seller was State Street, cutting an estimated $5.83M.

  • 134 institutional investors held Viking Therapeutics (VKTX) as of Q3 2021, down from 138 in Q2 2021.
  • Funds reported $238M of Viking Therapeutics stock for Q3 2021, up 4.9% quarter-over-quarter.
  • 9 funds opened new Viking Therapeutics positions in Q3 2021 and 12 closed out, a net change of -3 holders.
  • The largest Viking Therapeutics buyer in Q3 2021 was Nuveen, an estimated $5.13M added.
  • The largest Viking Therapeutics seller in Q3 2021 was State Street, an estimated $5.83M sold.

Based on aggregated 13F filings for Q3 2021.